COMMUNIQUÉ DE PRESSE publié le 30/04/2024 à 20:30, il y a 6 mois 21 jours Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024. Spexis AG receives approval to extend deadline for publishing 2023 annual report and audited financials until May 31, 2024, due to ongoing legal discussions and negotiations with creditors Extension 2023 Annual Report Spexis AG Deadline Audited Financials
BRÈVE publiée le 17/04/2024 à 07:20, il y a 7 mois 4 jours Spexis AG annonce des développements importants, notamment un moratoire prolongé et des modifications stratégiques en matière de licences Spexis SA Prolongation Du Moratoire OMPTA Vente De Programmes Précliniques Licence Lonodelestat
BRÈVE publiée le 17/04/2024 à 07:20, il y a 7 mois 4 jours Spexis AG Announces Significant Developments Including Extended Moratorium and Strategic Licensing Changes Spexis AG Moratorium Extension OMPTAs Preclinical Program Sale Lonodelestat Licensing
COMMUNIQUÉ DE PRESSE publié le 17/04/2024 à 07:15, il y a 7 mois 4 jours Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera Spexis AG extends moratorium and receives payment for antibiotics program sale while reverting lonodelestat license from Santhera Spexis AG Moratorium Extension Antibiotics Program Sale Lonodelestat License Santhera
COMMUNIQUÉ DE PRESSE publié le 08/02/2024 à 07:15, il y a 9 mois 13 jours Spexis announces closing of sale of preclinical antibiotics program to Basilea Spexis AG announces the closing of the sale of a preclinical antibiotics program to Basilea, which will pay up to CHF 2 million for the program. The program targets Gram-negative bacteria, including multidrug-resistant strains. The sale is part of Spexis' strategy to divest non-core programs and assets to focus on rare diseases and oncology Spexis AG Basilea Preclinical Antibiotics Program Gram-negative Bacteria Multidrug-resistant Strains
COMMUNIQUÉ DE PRESSE publié le 08/11/2023 à 07:15, il y a 1 année Spexis to file an application for a debt-restructuring moratorium
COMMUNIQUÉ DE PRESSE publié le 01/11/2023 à 07:20, il y a 1 année Spexis Announces Changes to the Executive Committee
COMMUNIQUÉ DE PRESSE publié le 06/10/2023 à 07:30, il y a 1 année 1 mois Spexis to host business update conference call on October 9, 2023
COMMUNIQUÉ DE PRESSE publié le 29/09/2023 à 07:25, il y a 1 année 1 mois Spexis provides business update and announces financial results for the first half of 2023
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 07:30, il y a 1 année 1 mois Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology
Publié le 21/11/2024 à 06:58, il y a 13 heures 53 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 13 heures 53 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 13 heures 53 minutes Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 1 jour Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 1 jour 1 heure Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Publié le 21/11/2024 à 20:15, il y a 36 minutes Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Publié le 21/11/2024 à 20:10, il y a 41 minutes For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Publié le 21/11/2024 à 20:00, il y a 51 minutes Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Publié le 21/11/2024 à 19:25, il y a 1 heure 26 minutes Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine
Publié le 21/11/2024 à 17:35, il y a 3 heures 16 minutes 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Publié le 21/11/2024 à 19:01, il y a 1 heure 50 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 21/11/2024 à 18:36, il y a 2 heures 15 minutes Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Publié le 21/11/2024 à 17:58, il y a 2 heures 53 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 21/11/2024 à 17:51, il y a 3 heures LIGHTON announces highly successful IPO on Euronext Growth Paris.
Publié le 21/11/2024 à 17:51, il y a 3 heures LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.